Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review
journal contribution
submitted on 2023-03-15, 08:01 and posted on 2023-03-16, 06:19 authored by Fateen Ata, Safna Farsana Akkam Veettil, Mohammed Gaber, Nabil E. Omar, Ammar Madani, Hebatalla Mah. Afifi, Meeloud M. Aldardouri, Aliaa Amer, Samah Kohla, Abdul Rehman Zar GulWhen seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.
Other Information
Published in: Clinical Case Reports
License: http://creativecommons.org/licenses/by/4.0/
See article on publisher's website: http://dx.doi.org/10.1002/ccr3.3860
History
Language
- English
Publisher
WileyPublication Year
- 2021
Institution affiliated with
- Hamad Medical Corporation
- National Center for Cancer Care and Research (Hamad Medical Corporation)
